Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSelf-StudyEvaluation, Staging, and Monitoring of Chronic Hepatitis C
Evaluation, Staging, and Monitoring of Chronic Hepatitis C
Sign In or Register to get started
Evaluation, Staging, and Monitoring of Chronic Hepatitis C
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 2 Overview
Natural History of HCV Infection - 0%Topic 1
Spontaneous Clearance versus Chronic InfectionActivities- 0%Topic 2
Variable Outcomes of Chronic InfectionActivities- 0%Topic 3
Host Factors that Impact Rate of Fibrosis ProgressionActivities- 0%Topic 4
Viral Factors that Impact Rate of Fibrosis ProgressionNatural History of HCV Infection Overview
About this Lesson
Last Updated: March 16th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: July 1st, 2013CNE and CME Review: April 11th, 2024CNE and CME Expiration: April 10th, 2027 (4th Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Natural History of HCV Infection and available until April 11th, 2024.Learning Objectives
- Explain spontaneous viral clearance versus persistent infection following initial HCV acquisition
- Describe the variable outcomes that can occur in persons with chronic HCV infection
- Summarize the typical time course for developing liver complications in untreated chronic HCV
- List factors that influence the rate of progression of fibrosis in persons with chronic HCV infection
- Discuss the impact of alcohol intake on fibrosis progression in persons with chronic HCV infection
Lesson Contributors
Authors
Maria A. Corcorran, MD, MPHMaria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneDavid H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
Copyright © 2024 Hepatitis C Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-c8843673-2024-11-13-205624